| Ticker Details |
Orthofix Medical Inc.
Orthofix International NV is a medical device company. It focuses on providing reconstructive and regenerative orthopedic and spine solutions to physicians.
|
| IPO Date: |
April 24, 1992 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$549.25M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.47 | 1.46%
|
| Avg Daily Range (30 D): |
$0.23 | 1.63%
|
| Avg Daily Range (90 D): |
$0.25 | 1.68%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.13M |
| Avg Daily Volume (30 D): |
.17M |
| Avg Daily Volume (90 D): |
.17M |
| Trade Size |
| Avg Trade Size (Sh.): |
85 |
| Avg Trade Size (Sh.) (30 D): |
42 |
| Avg Trade Size (Sh.) (90 D): |
43 |
| Institutional Trades |
| Total Institutional Trades: |
2,647 |
| Avg Institutional Trade: |
$1.33M |
| Avg Institutional Trade (30 D): |
$.66M |
| Avg Institutional Trade (90 D): |
$.69M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.2M |
| Avg Closing Trade (30 D): |
$.63M |
| Avg Closing Trade (90 D): |
$.67M |
| Avg Closing Volume: |
48.24K |
|
|
| News |
Aug 6, 2025 @ 2:16 AM
Orthofix (OFIX) Q2 Revenue Rises 2%
Source: Jesterai
|
Apr 10, 2025 @ 5:30 AM
Intramedullary Nail Market size to worth USD 1,537...
Source: Coherent Market Insights
|
Feb 28, 2025 @ 3:56 PM
Prosthetic Disc Nucleus Market Outlook to Exceed U...
Source: Transparency Market Research Inc.
|
Nov 8, 2024 @ 9:00 PM
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Oct 30, 2024 @ 1:00 AM
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Inv...
Source: N/A
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-3.03
|
$-.57
|
$-.36
|
|
Diluted EPS
|
$-3.03
|
$-.57
|
$-.36
|
|
Revenue
|
$818.06M
|
$205.63M
|
$203.12M
|
|
Gross Profit
|
$558.52M
|
$148.52M
|
$139.53M
|
|
Net Income / Loss
|
$-119.12M
|
$-22.8M
|
$-14.08M
|
|
Operating Income / Loss
|
$-93.4M
|
$-17.05M
|
$-16M
|
|
Cost of Revenue
|
$259.54M
|
$57.11M
|
$63.59M
|
|
Net Cash Flow
|
$32.84M
|
$-2.64M
|
$7.18M
|
|
PE Ratio
|
|
|
|
|
|
|